Skip to content

A Study for Newly Diagnosed Patients with Retinoblastoma in India

A Prospective Collaborative Study for Newly Diagnosed Patients with Retinoblastoma in India - InPOG-Rb-19-01

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027846
Enrollment
570
Registered
2020-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

None listed

Sponsors

Cankids Kidscan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1. Age 2. All new patients must be staged and should be enrolled within 4 weeks of diagnosis and staging. If staged previously, they must be formally reassessed. 3. Informed consent should be taken from all parents for enrolling the subjects in this study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria Patients who have relapsed after completion of frontline treatment.

Design outcomes

Primary

MeasureTime frame
Overall Survival Event Free SurvivalTimepoint: 5 Years from date of Diagnosis of Disease / Recruitment date (last patient is estimated to be recruited from 3 years of start of recruitment) 1- year and subsequent year survival rate will also be analyzed and presented

Secondary

MeasureTime frame
Factors leading to delayed treatment visual outcomes for patients with ocular salvageTimepoint: 1 year

Countries

India

Contacts

Public ContactDr Amita Mahajan

Dr. Shroffs Charity Eye Hospital, Delhi

contactsima@gmail.com9910190098

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026